Tonix Pharmaceuticals Holding Corp (TNXP)
SG&A Expense Growth
28.11%
Quarterly · Period ending:
TNXP SG&A Expense Growth
Latest reported28.11%period ending
Latest reported28.11%period ending
TNXP Quarterly SG&A Growth (QoQ) (0.00% → 28.11%)
Latest values, visible window
High-resolution chart · PNG
TNXP sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 28.1093% | |
| -20.2336% | |
| 0% | |
| 0% | |
| -100% | |
| -35.1559% | |
| 0% | |
| -100% | |
| -19.42% | |
| -8.0948% | |
| 16.2764% | |
| 23.9966% | |
| -4.9384% | |
| -8.2319% | |
| 8.9851% | |
| 9.3681% | |
| -15.6851% | |
| 11.569% | |
| 31.7257% | |
| 0.4421% | |
| 0.3698% | |
| 9.8051% | |
| 54.6139% | |
| -12.0133% | |
| 38.1534% | |
| -13.8962% | |
| 7.2209% | |
| 20.7058% | |
| -2.0408% | |
| -7.4046% | |
| 13.8779% | |
| 9.6821% | |
| 14.1914% | |
| -4.7669% | |
| -0.9341% | |
| -4.4147% | |
| -3.8627% | |
| -20.2965% | |
| 22.7718% | |
| -7.6293% | |
| -30.6013% | |
| -14.545% | |
| 31.8948% | |
| 1.8194% | |
| 1.6045% | |
| -11.2109% | |
| 45.6473% | |
| 12.31% | |
| 21.9271% | |
| -32.0319% | |
| 63.7279% | |
| 27.4293% | |
| -9.4322% | |
| 3.6661% | |
| 12.9917% | |
| 5.1849% | |
| 34.1419% | |
| -65.5027% | |
| 95,119.9828% | |
| 53.1662% | |
| -72.5113% | |
| 203.8567% | |
| -50.7463% | |
| 53.4138% | |
| -58.7427% | |
| 67.2028% | |
| 33.2568% | |
| -51.6827% | |
| 128.7648% | |
| -73.666% | |
| 272.1808% | |
| -6.8366% | |
| 5,653.3333% | |
| 0% |